Dave Mehalick
Found 8 people in Pennsylvania, Florida, Texas and other states
-
+97
-
+96
-
+95
-
-
+93
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dave Mehalick - @DaveMehalick_
Sponsored by SpokeoPaid Service
Sponsored by PeopleLookerPaid Service
Sponsored by SpokeoPaid Service
Dave Mehalick
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Moineaud Malick Davo
@moineaudmalick.davo
DaveMehalick - @davemehalick
57 followers
davemehalick767 - @davemehalick767
10 followers
David Mehalick - @davidmehalick
45 followers
davemihalick - @davemihalick
1 follower
Dave Mehalshick - @dave.mehalshick
13 followers
Dave Mehalick
Chief Executive Officer at Coeptis ...
Rick Nolan
BluChip
Education: West Virginia University ...
Roy Failla
ARIVE CAPITAL MARKETS
Dave Mehalick
-
Immaculata High School (1982 - 1986)
Somerville, NJ
David Mehalick
-
Transfiguration School (1978 - 1982)
West Hazleton, PA
Dave Mehalick
Sponsored by PeopleLookerPaid Service
Search for Dave Mehalick's city and state history
Search address historyHere's what to know about the Coeptis-Z-Squared merger
The Business Journals - Mon, 28 Apr 2025
Biopharma firm spins off cancer research to mine Dogecoin instead
dlnews.com - Sat, 26 Apr 2025
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
citybiz - Wed, 17 May 2023
Coeptis dives 40% on Dogecoin mining pivot with Z Squared merger
The Block - Fri, 25 Apr 2025
Massive Crypto Pivot: Biotech Firm Acquires 9,000 Dogecoin Miners in Industry-Shaking Merger
Stock Titan - Fri, 25 Apr 2025
User
FinancialContent - Fri, 17 Jan 2025
Coeptis to acquire Dogecoin miner, spin off biopharma operations
The Business Journals - Mon, 28 Apr 2025
Coeptis Therapeutics and Z Squared to Merge
citybiz - Fri, 25 Apr 2025
Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer
citybiz - Wed, 30 Aug 2023
Dave Mehalick - @bigdave12241
7 followers
About | Coeptis Therapeutics
Management has demonstrated a track record of acquiring and developing novel therapies. Dave Mehalick. Chairman, President and Chief Executive Officer.
Dave Mehalick - IMDb
Dave Mehalick. Producer: Bar Starz. Dave Mehalick is known for Bar Starz (2008) and Three Days to Vegas (2007).
Dave Mehalick,Coeptis Therapeutics - Investment Reports
Dave Mehalick, Chairman - President & CEO, Coeptis Therapeutics. 17 February 2023. Share Interview.
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing ...
Dave Mehalick, President and CEO of Coeptis, stated, "This strategic move not only reinforces our commitment to innovation but also ...
Coeptis Therapeutics Chief Executive Officer, Dave Mehalick ...
Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders. (PRNewsfoto ...
Dave Mehalick, Author at Jabez Biosciences
Dave Mehalick. Joined: July 10, 2024; Articles: 1. Press Releases · Multi-institutional team awarded NCI grant to open novel AML trial · Dave Mehalick; June 23 ...
Universal Approach to Cell Therapy Using SNAP-CAR with ...
Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and ...
Dave Mehalick - Coeptis Pharmaceuticals - The Org
Dave Mehalick is the Chief Executive Officer and Cofounder of Coeptis Therapeutics since October 2016. Prior to that, they worked as the Managing Director ...
Dave Mehalick - aVenture Research
Learn more about Dave Mehalick including their work at Coeptis Pharmaceuticals and Coeptis Therapeutics.
$COEP - "We thank the Nasdaq Hearings Panel for approving ...
$COEP - "We thank the Nasdaq Hearings Panel for approving our request," said Coeptis' Chief Executive Officer Dave Mehalick.
Dave Mehalick - Chairman, President & CEO at Coeptis ...
Dave Mehalick. Chairman, President & CEO. Contact. Mr. Mehalick is a successful ... Org chart. Dave Mehalick's profile picture. Dave Mehalick. Chairman ...
Monarch Therapeutics & SNAP Biosciences Enter Licensing ...
“We are thrilled to incorporate this innovative adaptor technology into our Snap-Car NK platform,” said Dave Mehalick, CEO at Coeptis ...
Coeptis Therapeutics Holdings Expands Board of Directors ...
Dave Mehalick ... and Coeptis' emergence as a Nasdaq-traded company,” said Dave Mehalick, President and CEO of Coeptis Therapeutics Holdings.
Partnering News | Office of Industry and Economic Partnerships
December 19, 2022 - Dr. Jason Lohmueller, Assistant Professor with Pitt's Department of Immunology is joined by Coeptis Therapeutics' CEO, Dave Mehalick, on ...
Amendment #1 to Option Purchase Agreement CD38-SNP-DIAG
COEPTIS PHARMACEUTICALS, INC. /s/ David Mehalick Its: CEO. Dave Mehalick.
[PDF] Coeptis Therapeutics Inc. - Barchart Market Data Solutions
/s/ Dave Mehalick. Dave Mehalick. President. 2021-07-27. Persons who respond to the collection of information contained in this form are not required to respond.